Skip to main content
. 2006 Mar 1;6(5):1–70.

Table 7: Adverse Events in MUST-EECP.(33).

Adverse Events Inactive-CP
(n=66)
Active-CP
(n=71)
P value
Number of patients with adverse events 17(25.8%) 39(54.9%) <0.001
Non-device related
Viral syndrome 0 1 >0.5
Anxiety 0 2 =0.5
Dizziness 1 3 >0.5
Tinnitus 0 1 >0.5
GI disturbance 1 1 >0.5
Headache 0 1 >0.5
Blood pressure change 1 1 >0.5
Epistaxis 0 2 =0.5
Angina 1 1 >0.5
“Other” chest pain 3 9 =0.3
A/V arrhythmia 3 9 >0.2
Heart rate change (sinusal) 3 0 =0.1
Respiratory 2 4 >0.5
Total non-device related 15 33 <0.005
Device related
Paresthesia 1 2 >0.5
Edema, swelling 0 2 =0.5
Skin abrasion, bruise, blister 2 13 =0.005
Pain (legs, back) 7 20 =0.01
Total device related 10 37 <0.001

Reprinted from the Journal of the American College of Cardiology, v. 33, Arora RR, Chou TM, Jain D, Fleishman B, Crawford L, McKiernan T, Nesto RW. The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise induced myocardial ischemia and anginal episodes, 1833-1840, Copyright 1999, with permission from the American College of Cardiology Foundation.